Annals of Emergency Medicine
Volume 45, Issue 1 , Pages 32-36 , January 2005

Another resident perspective: Resident education and the pharmaceutical industry: Another resident perspective: Resident education and the pharmaceutical industry

  • Peter J. Peraud, MD
    • ,
  • Erik B. Kulstad, MS, MD

      Affiliations

    • Corresponding Author InformationAddress for correspondence: Erik B. Kulstad, MD, MS, 4440 W. 95th Street, Oak Lawn, IL 60453; 708-346-5375

References 

  1. Keim SM, Mays MZ, Grant D. Interactions between emergency medicine programs and the pharmaceutical industry. Acad Emerg Med. 2004;11:19–26
  2. McCormick BB, Tomlinson G, Brill-Edwards P, et al. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA. 2001;286:1994–1999
  3. Peppin JF. An Engelhardtian analysis of interactions between pharmaceutical sales representatives and physicians. J Med Philos. 1997;22:623–641
  4. Waud DR. Pharmaceutical promotions—a free lunch?. N Engl J Med. 1992;327:351–353
  5. Coyle SL. Physician-industry relations. Part 1: individual physicians. Ann Intern Med. 2002;136:396–402
  6. Government Accounting Office. General Accounting Office report to congressional requesters: prescription drugs—FDA oversight of direct-to-consumer advertising has limitations. 2002. Available at: http://www.gao.gov/new.items/d03177.pdf. Accessed April 5, 2004.
  7. Bukata W. Biomedical research: reader beware. Emerg Med Acute Care Essays. 2003;27:1–4
  8. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift?. JAMA. 2000;283:373–380
  9. Reeder M, Dougherty J, White LJ. Pharmaceutical representatives and emergency medicine residents: a national survey. Ann Emerg Med. 1993;22:1593–1596
  10. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73:4–8
  11. Orlowski JP, Wateska L. The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch. Chest. 1992;102:270–273
  12. Rothman KJ. Conflict of interest. The new McCarthyism in science. JAMA. 1993;269:2782–2784
  13. Moskop JC. Emergency physicians and gifts from industry [American College of Emergency Physicians Web site]. Available at: http://www.acep.org/1,5248,0.html. Accessed April 5, 2004.
  14. Accreditation Council for Continuing Medical Education Web site. Standards for commercial support of continuing medical education. 1992. Available at: http://www.accme.org/pdfs/disclosure_pol.pdf. Accessed April 5, 2004.
  15. American Medical Association Web site. Gifts to physicians from industry. 1998. Available at: http://www.ama-assn.org/ama/pub/article/4001-7922.html. Accessed April 5, 2004.
  16. Society for Academic Emergency Medicine. Policy on commercial support of SAEM activities. Available at: http://www.saem.org/inform/commerci.htm. Accessed September 20, 2004.
  17. Ferguson RP, Rhim E, Belizaire W, et al. Encounters with pharmaceutical sales representatives among practicing internists. Am J Med. 1999;107:149–152
  18. Lipsky MS, Taylor CA. The opinions and experiences of family physicians regarding direct-to-consumer advertising. J Fam Pract. 1997;45:495–499
  19. Keim S, Perina DG. Council of Emergency Medicine Residency Directors position on interactions between emergency medicine residencies and the pharmaceutical industry. Acad Emerg Med. 2004;11:78
  20. Hopper JA, Speece MW, Musial JL. Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives. J Gen Intern Med. 1997;12:639–642
  21. Shaughnessy AF, Slawson DC, Bennett JH. Teaching information mastery: evaluating information provided by pharmaceutical representatives. Fam Med. 1995;27:581–585
  22. Wilkes MS, Hoffman JR. An innovative approach to educating medical students about pharmaceutical promotion. Acad Med. 2001;76:1271–1277
  23. Kirby D. The impact of schools and school programs upon adolescent sexual behavior. J Sex Res. 2002;39:27–33
  24. Coyle SL. Physician-industry relations. Part 2: organizational issues. Ann Intern Med. 2002;136:403–406
  25. Molzen GW. ACEP comment letter to OIG [American College of Emergency Physicians Web site]. 2002. Available at: http://www.acep.org/library/pdf/pharmmfrs.pdf. Accessed April 5, 2004.
  26. FitzGerald JD, Wenger NS. Didactic teaching conferences for IM residents: who attends, and is attendance related to medical certifying examination scores?. Acad Med. 2003;78:84–89
  27. Sidorov J. How are internal medicine residency journal clubs organized, and what makes them successful?. Arch Intern Med. 1995;155:1193–1197
  28. Carruthers SG. Assimilating new therapeutic interventions into clinical practice: how does hypertension compare with other therapeutic areas?. Am Heart J. 1999;138:256–260
  29. Hoffman JR, Wilkes M. Direct to consumer advertising of prescription drugs. An idea whose time should not come. BMJ. 1999;318:1301–1302
  30. Lavoie D. Eleven drug-company executives face trial in kickback case. The Seattle Times. April 13, 2004. Available at: http://seattletimes.nwsource.com/cgi-bin/PrintStory.pl?document_id=2001901813&zsection_id-268448455&slug=drugtrial13&date=20040413. Accessed October 28, 2004.
  31. Goodman R. No free lunch: just say no to drug reps. Available at: http://www.nofreelunch.org. Accessed April 13, 2004.
  32. Department of Essential Drugs and Medicines Policy Drug Promotion Database. Available at: http://www.drugpromo.info/. Accessed April 13, 2004.

 The authors report this study did not receive any outside funding or support.Reprints not available from the authors.

PII: S0196-0644(04)01581-1

doi: 10.1016/j.annemergmed.2004.10.028

Annals of Emergency Medicine
Volume 45, Issue 1 , Pages 32-36 , January 2005

Article Tools